| Cytokine alterations in panic disorder: a systematic review LA Quagliato, AE Nardi Journal of affective disorders 228, 91-96, 2018 | 77 | 2018 |
| Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines LA Quagliato, RC Freire, AE Nardi Expert opinion on drug safety 17 (3), 315-324, 2018 | 49 | 2018 |
| Depression and anxiety among online learning students during the COVID-19 pandemic: a cross-sectional survey in Rio de Janeiro, Brazil L Pelucio, P Simões, MCN Dourado, LA Quagliato, AE Nardi BMC psychology 10 (1), 192, 2022 | 47 | 2022 |
| Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: a meta-analysis of common side effects in acute treatment LA Quagliato, F Cosci, RI Shader, EK Silberman, V Starcevic, R Balon, ... Journal of Psychopharmacology 33 (11), 1340-1351, 2019 | 30 | 2019 |
| Maternal immune activation generates anxiety in offspring: A translational meta-analysis LA Quagliato, U de Matos, AE Nardi Translational psychiatry 11 (1), 245, 2021 | 25 | 2021 |
| The relationship between emotional regulation and hemispheric lateralization in depression: a systematic review and a meta-analysis N Horato, LA Quagliato, AE Nardi Translational psychiatry 12 (1), 162, 2022 | 24 | 2022 |
| The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies LA Quagliato, RC Freire, AE Nardi Translational psychiatry 8 (1), 185, 2018 | 23 | 2018 |
| Panic disorder respiratory subtype: psychopathology and challenge tests–an update RT Okuro, RC Freire, WA Zin, LA Quagliato, AE Nardi Brazilian Journal of Psychiatry 42, 420-430, 2020 | 16 | 2020 |
| The role of convergent ion channel pathways in microglial phenotypes: a systematic review of the implications for neurological and psychiatric disorders LA Quagliato, AE Nardi Translational Psychiatry 8 (1), 259, 2018 | 15 | 2018 |
| Elevated peripheral kynurenine/tryptophan ratio predicts poor short-term auditory memory in panic disorder patients LA Quagliato, RC Freire, AE Nardi Journal of Psychiatric Research 113, 159-164, 2019 | 12 | 2019 |
| Cytokine profile in drug-naïve panic disorder patients LA Quagliato, AE Nardi Translational Psychiatry 12 (1), 75, 2022 | 8 | 2022 |
| Improving the perception of respect for and the dignity of inpatients: a systematic review PEP Dutra, LA Quagliato, AE Nardi BMJ open 12 (5), e059129, 2022 | 7 | 2022 |
| International Task Force on Benzodiazepines. Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute … LA Quagliato, F Cosci, RI Shader Journal of Psychopharmacology 33, 1340-1351, 2019 | 7 | 2019 |
| Benzodiazepines are efficacious and safe for long-term use: Clinical research data and more than sixty years in the market AE Nardi, LA Quagliato Psychotherapy and Psychosomatics 91 (5), 300-303, 2022 | 6 | 2022 |
| Clinical utility of semistructured interview and scales to assess withdrawal syndromes with dose reduction or discontinuation of selective serotonin reuptake inhibitors or … F Cosci, S Romanazzo, G Mansueto, P Rontani, MN Levitan, ... Journal of Clinical Psychopharmacology 42 (1), 17-22, 2022 | 6 | 2022 |
| Physical abuse during childhood predicts IL-2R levels in adult panic disorder patients LA Quagliato, DA Coelho, UMA de Matos, AE Nardi Journal of affective disorders 295, 1440-1444, 2021 | 5 | 2021 |
| Catatonia and psychosis related to epilepsy: A case report L Quagliato, R Piedade, C Santana, E Cheniaux Clinical Schizophrenia & Related Psychoses 12 (3), 142-144, 2018 | 5 | 2018 |
| Lifetime psychopathology in the offspring of parents with anxiety disorders: A systematic review LA Quagliato, UMA de Matos, AE Nardi Journal of Affective Disorders 319, 618-626, 2022 | 4 | 2022 |
| A cross-sectional healthy-control study of serum inflammatory biomarkers interleukin (IL)-1B and IL-2R in panic disorder patients and their offspring LA Quagliato, AE Nardi Journal of psychiatric research 149, 260-264, 2022 | 4 | 2022 |
| A Brazilian case of treatment-resistant generalized anxiety disorder successfully treated with monoamine oxidase inhibitor (MAOI) CG Falcão Faria, M Fidry, M Costa do Cabo, L Azevedo Quagliato, ... Psychiatria Danubina 32 (suppl. 1), 139-141, 2020 | 4 | 2020 |
Antonio Egidio NardiProfessor of Psychiatry, Universidade Federal do Rio de JaneiroE-mail confirmado em pq.cnpq.br
